Detalhe da pesquisa
1.
Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers.
J Hepatol
; 80(1): 31-40, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827470
2.
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
EMBO Rep
; 23(2): e54341, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914162
3.
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Mol Ther
; 30(9): 2984-2997, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484842
4.
A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus.
Mol Ther
; 28(8): 1772-1782, 2020 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485138
5.
Human hematopoietic reconstitution and HLA-restricted responses in nonpermissive alymphoid mice.
J Immunol
; 193(3): 1504-11, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24973440
6.
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Gut
; 64(12): 1961-71, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25429051
7.
Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
J Virol
; 88(5): 3004-15, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371056
8.
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
Med Microbiol Immunol
; 204(1): 121-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25511871
9.
Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.
J Virol
; 87(10): 5554-63, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468504
10.
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Pharmaceutics
; 15(3)2023 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986707
11.
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Front Immunol
; 14: 1208041, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654495
12.
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
EMBO Mol Med
; 15(10): e17723, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675835
13.
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
Microbes Infect
; 25(7): 105142, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080384
14.
Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.
J Virol
; 85(19): 10201-12, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21775455
15.
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters.
Vaccines (Basel)
; 11(1)2022 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679857
16.
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
J Hepatol
; 54(6): 1286-96, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21238516
17.
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.
Commun Biol
; 4(1): 713, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112936
18.
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
EMBO Mol Med
; 13(12): e14459, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647691
19.
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Cell Host Microbe
; 29(2): 236-249.e6, 2021 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357418
20.
Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.
Hepatology
; 50(5): 1380-91, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19821533